» Articles » PMID: 37637998

Exploratory Study of Macrophage Polarization and Spatial Distribution in Colorectal Cancer Liver Metastasis: a Pilot Study

Overview
Journal Front Immunol
Date 2023 Aug 28
PMID 37637998
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The liver is the most typical site of metastatic disease for patients with colorectal cancer (CRC), and up to half the patients with CRC will develop colorectal liver metastasis (CLM). Studying the tumor microenvironment, particularly macrophages and their spatial distribution, can give us critical insight into treatment.

Methods: Ten CLMs (five treatment-naïve and five post-neoadjuvant chemotherapy) were stained with multiplex immunofluorescence panels against cytokeratins, CD68, Arg1, CD206, CD86, CD163, PD-L1, and MRP8-14. Densities of cell phenotypes and their spatial distribution in the tumor center and the normal liver-tumor interface were correlated with clinicopathological variables.

Results: M2 macrophages were the predominant subtype in both the tumor center and the periphery, with a relatively higher density at the periphery. The larger tumors, more than 3.9 cm, were associated with higher densities of total CD68+ macrophages and CD68+CD163+ CD206 and CD68+CD206+ CD163 M2 macrophage subtypes. Total macrophages in the tumor periphery demonstrated significantly greater proximity to malignant cells than did those in the tumor center (p=0.0371). The presence of higher than median CD68+MRP8-14+CD86 M1 macrophages in the tumor center was associated with poor overall survival (median 2.34 years) compared to cases with lower than median M1 macrophages at the tumor center (median 6.41 years) in univariate analysis.

Conclusion: The dominant polarization of the M2 macrophage subtype could drive new therapeutic approaches in CLM patients.

Citing Articles

Biological Roles and Clinical Therapeutic Applications of Tumor-Associated Macrophages in Colorectal Liver Metastasis.

Li S, Hao L, Hu X J Inflamm Res. 2024; 17:8429-8443.

PMID: 39529996 PMC: 11552512. DOI: 10.2147/JIR.S493656.


Defining and modeling dynamic spatial heterogeneity within tumor microenvironments.

Bareham B, Dibble M, Parsons M Curr Opin Cell Biol. 2024; 90:102422.

PMID: 39216233 PMC: 11846781. DOI: 10.1016/j.ceb.2024.102422.


Role of Tumor-Associated Macrophages in Cervical Cancer: Integrating Classical Perspectives with Recent Technological Advances.

Choi Y, Lee D, Kim N, Seo I, Park N, Chong G Life (Basel). 2024; 14(4).

PMID: 38672714 PMC: 11051155. DOI: 10.3390/life14040443.

References
1.
Yu C, Wortman J, He T, Solomon S, Zhang R, Rosario A . Physics approaches to the spatial distribution of immune cells in tumors. Rep Prog Phys. 2020; 84(2):022601. DOI: 10.1088/1361-6633/abcd7b. View

2.
Speel E, Hopman A, Komminoth P . Amplification methods to increase the sensitivity of in situ hybridization: play card(s). J Histochem Cytochem. 1999; 47(3):281-8. DOI: 10.1177/002215549904700302. View

3.
Lin E, Pollard J . Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res. 2007; 67(11):5064-6. DOI: 10.1158/0008-5472.CAN-07-0912. View

4.
Stack E, Wang C, Roman K, Hoyt C . Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis. Methods. 2014; 70(1):46-58. DOI: 10.1016/j.ymeth.2014.08.016. View

5.
Parra E, Jiang M, Solis L, Mino B, Laberiano C, Hernandez S . Procedural Requirements and Recommendations for Multiplex Immunofluorescence Tyramide Signal Amplification Assays to Support Translational Oncology Studies. Cancers (Basel). 2020; 12(2). PMC: 7072187. DOI: 10.3390/cancers12020255. View